Literature DB >> 8033422

Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.

M C Aldhous1, K C Watret, J Y Mok, A G Bird, K S Froebel.   

Abstract

HIV-specific cytotoxic T lymphocytes (CTL) are thought to play a major role in viral control in HIV-infected adults. Changes in the relative proportions of CD8 lymphocyte subpopulations are also thought to be associated with disease progression. Less is known about the relative effectiveness of CTL against different HIV targets, or about the relationship, if any, between CTL activity and CD8 subpopulations. We have measured CTL activity against four HIV gene products (gag, tat, pol and env) and expression of CD45RO, CD45RA, HLA-DR, CD29, S6F1, and CD57 surface markers on CD8 cells from nine HIV-infected and 11 HIV-uninfected children. Of nine HIV-infected children, six showed antigen-specific CTL activity on at least one occasion: 4/6 directed against tat, 6/6 against pol, 1/6 against env, and 1/6 against gag. However, the specificity of the CTL activity varied between children and within individual children with time. Furthermore, two uninfected children showed CTL activity, one to HIV-gag, -pol and -tat, and the other to HIV-pol. All the HIV-infected and two uninfected children had abnormal proportions of CD8 subpopulations in whole blood compared with age-matched controls. There was no correlation between CTL activity and CD8 subsets in whole blood. Five children changed from CTL-positive to CTL-negative (or vice versa) during the study. In these, the occasions when CTL activity was detected coincided with an increase in CD8 cells, an expansion of HLA-DR+ CD8 cells and a loss of CD45RA+ CD8 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033422      PMCID: PMC1534797          DOI: 10.1111/j.1365-2249.1994.tb06580.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes.

Authors:  P Joly; J M Guillon; C Mayaud; F Plata; I Theodorou; M Denis; P Debre; B Autran
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

2.  Vertical transmission of HIV: a prospective study.

Authors:  J Y Mok; R A Hague; P L Yap; F D Hargreaves; J M Inglis; J M Whitelaw; C M Steel; O B Eden; S Rebus; J F Peutherer
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

3.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

Authors:  D F Nixon; A R Townsend; J G Elvin; C R Rizza; J Gallwey; A J McMichael
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

4.  Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones.

Authors:  K K Sethi; H Näher; I Stroehmann
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

5.  The management of children born to human immunodeficiency virus seropositive women.

Authors:  J Y Mok; R A Hague; R F Taylor; R P Brettle; F D Hargreaves; J M Inglis; P L Yap
Journal:  J Infect       Date:  1989-03       Impact factor: 6.072

6.  Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children.

Authors:  S Plaeger-Marshall; P Hultin; J Bertolli; S O'Rourke; R Kobayashi; A L Kobayashi; J V Giorgi; Y Bryson; E R Stiehm
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-09

7.  AIDS virus-specific cytotoxic T lymphocytes in lung disorders.

Authors:  F Plata; B Autran; L P Martins; S Wain-Hobson; M Raphaël; C Mayaud; M Denis; J M Guillon; P Debré
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

8.  An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules.

Authors:  B Culmann; E Gomard; M P Kiény; B Guy; F Dreyfus; A G Saimot; D Sereni; J P Lévy
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

9.  Class II (DR) antigen expression on CD8+ lymphocyte subsets in acquired immune deficiency syndrome (AIDS).

Authors:  H W Ziegler-Heitbrock; D Stachel; T Schlunk; L Gürtler; W Schramm; M Fröschl; J R Bogner; G Riethmüller
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

10.  T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study.

Authors:  J V Giorgi; R Detels
Journal:  Clin Immunol Immunopathol       Date:  1989-07
View more
  15 in total

Review 1.  Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 2.  The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Authors:  C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

3.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

Review 4.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

Review 5.  Mechanisms of resistance to HIV infection.

Authors:  W A Paxton; R A Koup
Journal:  Springer Semin Immunopathol       Date:  1997

Review 6.  The Immune System of HIV-Exposed Uninfected Infants.

Authors:  Bahaa Abu-Raya; Tobias R Kollmann; Arnaud Marchant; Duncan M MacGillivray
Journal:  Front Immunol       Date:  2016-09-28       Impact factor: 7.561

7.  In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers.

Authors:  Diana B Schramm; Louise Kuhn; Glenda E Gray; Caroline T Tiemessen
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

8.  Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission.

Authors:  L Kuhn; S Meddows-Taylor; G Gray; D Trabattoni; M Clerici; G M Shearer; C Tiemessen
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

9.  Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.

Authors:  J T Qiu; B Liu; C Tian; G N Pavlakis; X F Yu
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 10.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.